Literature DB >> 3036967

Human monkeypox: clinical features of 282 patients.

Z Jezek, M Szczeniowski, K M Paluku, M Mutombo.   

Abstract

We present the clinical features and course of 282 patients with human monkeypox in Zaire during 1980-1985. The ages of the patients ranged from one month to 69 years; 90% were less than 15 years of age. The clinical picture was similar to that of the ordinary and modified forms of smallpox. Lymphadenopathy, occurring in the early stage of the illness, was the most important sign differentiating human monkeypox from smallpox and chickenpox. The symptoms, signs, and the course of the disease in patients who had been vaccinated against smallpox differed significantly from those in unvaccinated subjects. Pleomorphism and "cropping" similar to that in chickenpox occurred in 31% of vaccinated and 18% of unvaccinated patients. The prognosis depended largely on the presence of severe complications. No deaths occurred among vaccinated patients. In unvaccinated patients the crude case-fatality rate was 11% but was higher among the youngest children (15%).

Entities:  

Mesh:

Year:  1987        PMID: 3036967     DOI: 10.1093/infdis/156.2.293

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  82 in total

1.  Human Monkeypox in the Kivus, a Conflict Region of the Democratic Republic of the Congo.

Authors:  Andrea M McCollum; Yoshinori Nakazawa; Guy Mutombo Ndongala; Elisabeth Pukuta; Stomy Karhemere; Robert Shongo Lushima; Benoit Kebela Ilunga; Joelle Kabamba; Kimberly Wilkins; Jinxin Gao; Yu Li; Ginny Emerson; Inger K Damon; Darin S Carroll; Mary G Reynolds; Jean Malekani; Jean-Jacques Muyembe Tamfum
Journal:  Am J Trop Med Hyg       Date:  2015-08-17       Impact factor: 2.345

Review 2.  Emerging viral infections of the central nervous system: part 2.

Authors:  Kenneth L Tyler
Journal:  Arch Neurol       Date:  2009-09

3.  Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infection.

Authors:  Melissa E Dubois; Erika Hammarlund; Mark K Slifka
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

Review 4.  Human poxvirus infection after the eradication of smallpox.

Authors:  D Baxby
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

5.  Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route.

Authors:  Reed F Johnson; Julie Dyall; Dan R Ragland; Louis Huzella; Russell Byrum; Catherine Jett; Marisa St Claire; Alvin L Smith; Jason Paragas; Joseph E Blaney; Peter B Jahrling
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

6.  Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.

Authors:  Earl R Kern; Caroll Hartline; Emma Harden; Kathy Keith; Natalie Rodriguez; James R Beadle; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

7.  A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection.

Authors:  Marit Kramski; Kerstin Mätz-Rensing; Christiane Stahl-Hennig; Franz-Josef Kaup; Andreas Nitsche; Georg Pauli; Heinz Ellerbrok
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

8.  Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation.

Authors:  Erika Hammarlund; Anindya Dasgupta; Clemencia Pinilla; Patricia Norori; Klaus Früh; Mark K Slifka
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

Review 9.  Monkeypox virus and insights into its immunomodulatory proteins.

Authors:  Jessica R Weaver; Stuart N Isaacs
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

10.  Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity.

Authors:  Adam Macneil; Mary G Reynolds; Zach Braden; Darin S Carroll; Vanda Bostik; Kevin Karem; Scott K Smith; Whitni Davidson; Yu Li; Amba Moundeli; Jean-Vivien Mombouli; Aisha O Jumaan; D Scott Schmid; Russell L Regnery; Inger K Damon
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.